North America Electronic clinical Outcome Assessment (eCOA) Market - Industry Trends and Forecast to 2027

  • Healthcare IT
  • Published Report
  • Aug 2020
  • North America
  • 350 Pages
  • No of Tables: 21
  • No of Figures: 39

North America Electronic Clinical Outcome Assessment (eCOA) Market, By Product (On-Premise Solutions, Cloud Based Solutions and Web Based Solutions), Approach (Clinician Reported Outcome Assessment (CLINRO), Patient Reported Outcome Assessment (PRO), Observer Reported Outcome Assessment (OBSRO) and Performance Outcome Assessment (PERFO)), End User (Commercial Service Providers, Hospitals and Transplant Centers, Research Laboratories and Academic Institutions), Platform (Contract Research Organizations, Pharmaceutical and Biopharmaceutical Companies, Medical Device Manufacturers, Hospitals and Clinical Laboratories, Consulting Service Companies, Research and Academia and Others), Country (U.S., Canada, Mexico) Industry Trends and Forecast to 2027

North America Electronic Clinical Outcome Assessment (eCOA) MarketMarket Analysis and Insights: North America Electronic clinical Outcome Assessment (eCOA) Market

North America electronic clinical outcome assessment (eCOA) market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 15.8%in the forecast period of 2020 to 2027 and is expected to reach USD 1,114.55 million by 2027. Popularity of mHealth devices and introduction of advanced technologies for patient care and rising burden on pharmaceutical manufacturers to cut down overall costs for new drug development procedures are some of the factors which are aiding to the growth of the market.

Electronic clinical outcome assessment (eCOAs) determines the mental state, illness conditions, the outcome of a disease, and the patient's role in that situation. A medical evaluation can be the result of determining whether a drug is prescribing for treatment. Electronic clinical outcome assessment (eCOAs) involves Observer Reported Outcome Assessment (OBSRO), Patient Reported Outcome Assessment (PRO), Performance Outcome Assessment (PERFO), and Clinician Reported Outcome Assessment (CLINRO). There are many final users in the electronic community covering health issues such as hospitals, health centers, and clinical research organization (CROs) groups. Electronic clinical outcome assessment (eCOA) market has increased with initiatives pertaining to the adoption of eclinical platforms undertaken by various government and nonprofit organizations and growing acceptance of eCOA among clinical research professionals. For instance, In December 2019, Parexel International Corporation announced the starting of their new collaboration hub in the Cambridge Innovation Center (CIC), Cambridge, Mass. This collaboration has helped Paraxel International Corporation to connect and collaborate with the innovation hub at Cambridge and Kendall Square thus helped in its market expansion.

The rising awareness for the electronic clinical outcome assessment (eCOA) also increases the market value as the electronic clinical outcome assessment (eCOA) has repeatedly proven its high rates of effectiveness.

Currently various research studies are taking place which is expected to create a competitive advantage for manufacturers to develop new and innovative electronic clinical outcome assessment (eCOA) and expected to provide various other opportunities in the North America electronic clinical outcome assessment (eCOA) market. However, lack of proper healthcare IT infrastructure in developing countries is expected to restraint the market growth as to get approvals is difficult.

The North America electronic clinical outcome assessment (eCOA) market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the North America electronic clinical outcome assessment (eCOA) market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

North America Electronic clinical Outcome Assessment (eCOA) Market North America Electronic Clinical Outcome Assessment (eCOA) Market Scope and Market Size

North America electronic clinical outcome assessment (eCOA) market is segmented on the basis of product, approach, end user & platform. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of product, the electronic clinical outcome assessment (eCOA) market is segmented into on-premise solutions, cloud based solutions and web based solutions. In 2020, on premise solutions dominates the electronic clinical outcome assessment (eCOA) market as these are highly preferred due to the security they offer and the ability to provide highly customized features.
  • On the basis of approach, the electronic clinical outcome assessment (eCOA) market is segmented into clinician reported outcome assessment (CLINRO), patient reported outcome assessment (PRO), and observer reported outcome assessment (OBSRO) and performance outcome assessment (PERFO). In 2020 clinician reported outcome assessment (CLINRO) are dominating the market because it is the primary way of data collection and capturing data for clinical trials. As trained professionals involved in conducting the clinical trials are responsible for clinician reported outcome assessment, the volume of eCOA utilization is higher in this approach.
  • On the basis of end user, the electronic clinical outcome assessment (eCOA) market is segmented into commercial service providers, hospitals and transplant centers and research laboratories and academic institutions. In 2020, commercial service providers segment dominates the market due to the ability to manage the entire clinical trial where the sponsor does not have to invest time and efforts for the same.
  • On the basis of platform, the electronic clinical outcome assessment (eCOA) market is segmented into contract research organizations, pharmaceutical and biopharmaceutical companies, medical device manufacturers, hospitals and clinical laboratories, consulting service companies, research and academia and others. In 2020, contract research organizations are growing rapidly as a platform as most pharmaceutical companies prefer outsourcing their clinical trials to contract research organizations (CROs) as a third party service provider.  

North America Electronic clinical Outcome Assessment (eCOA) Market North America Electronic Clinical Outcome Assessment (eCOA) Market Country Level Analysis

North America electronic clinical outcome assessment (eCOA) market is analysed and market size information is provided by country, product, approach, end user and platform.  

The countries covered in the electronic clinical outcome assessment (eCOA) market report are the U.S., Mexico and Canada.   

In the North America market, the U.S. is dominating the North America electronic clinical outcome assessment (eCOA) market due to large number of companies, R & D capabilities and growing adoption of sequencing procedures. North America holds the major market share in the electronic clinical outcome assessment (eCOA) market due to the presence of major market players in that region. Canada is growing with the increasing healthcare initiatives by the government in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Increasing Product Launch, Product Expansion and Acquisitions in Electronic Clinical Outcome Assessment (eCOA) is creating new opportunities for these organizations in North America Electronic Clinical Outcome Assessment (eCOA) Market  

North America electronic clinical outcome assessment (eCOA) market also provides you with detailed market analysis for every country growth in sequencing industry with electronic clinical outcome assessment (eCOA) sales, impact of advancement in the electronic clinical outcome assessment (eCOA) and changes in regulatory scenarios with their support for the electronic clinical outcome assessment (eCOA) market. The data is available for historic period 2010 to 2018.

Competitive Landscape and Electronic Clinical Outcome Assessment (eCOA) Market Share Analysis

North America electronic clinical outcome assessment (eCOA) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Global presence, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to electronic clinical outcome assessment (eCOA) market.

The major players covered in the report are Bioclinica, Signant Health, eClinical Solutions LLC., ERT Clinical, Kayentis, Omnicomm, Parexel International Corporation, YPrime LLC, Clinical Ink, IBM Corporation, Oracle, WIRB-Copernicus Group and among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product launch and developments are also initiated by the companies worldwide which are also accelerating the North America electronic clinical outcome assessment (eCOA) market.  

For instance,

  • In June 2018, Bioclinica announced the availability of its expanded and enhanced 'SMART' technology suite with combined benefits of medical imaging, EDC and IRT. This efficient product launch with potential of unleasing data transparency and synchronous communication will be beneficial for Bioclinica as it has expanded its product portfolio and will raise its demand in market. Clinical study data sets, authorization, collaboration, acquisitions, joint ventures and other strategies by the market player is enhancing the company market in the North America electronic clinical outcome assessment (eCOA) market also provides the benefit for organisation to improve their offering for electronic clinical outcome assessment (eCOA).

Partnership, joint ventures and other strategies enhances the company market share with increased coverage and presence. It also provides the benefit for organisation to improve their offering for electronic clinical outcome assessment (eCOA) products through expanded range of products to enhance their business in the region.     

Customization Available: North America Electronic clinical Outcome Assessment (eCOA) Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.


SKU-

LIST OF TABLES 

 

TABLE 1 NORTH AMERICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 2 NORTH AMERICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY APPROACH, 2018-2027 (USD MILLION)

TABLE 3 NORTH AMERICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 4 NORTH AMERICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 5 NORTH AMERICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY COUNTRY, 2018-2027 (USD MILLION)

TABLE 6 NORTH AMERICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 7 NORTH AMERICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY APPROACH, 2018-2027 (USD MILLION)

TABLE 8 NORTH AMERICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 9 NORTH AMERICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY PLATFORM, 2018-2027 (USD MILLION)

TABLE 10 U.S. ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 11 U.S. ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY APPROACH, 2018-2027 (USD MILLION)

TABLE 12 U.S. ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 13 U.S. ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY PLATFORM, 2018-2027 (USD MILLION)

TABLE 14 CANADA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 15 CANADA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY APPROACH, 2018-2027 (USD MILLION)

TABLE 16 CANADA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 17 CANADA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY PLATFORM, 2018-2027 (USD MILLION)

TABLE 18 MEXICO ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 19 MEXICO ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY APPROACH, 2018-2027 (USD MILLION)

TABLE 20 MEXICO ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 21 MEXICO ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY PLATFORM, 2018-2027 (USD MILLION)

 

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19